J57-16877-18121
4 vaccinations
5 coded responses
27 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 211 / MD
- Registered
- 2021-12-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
UWV-44130-91162
Child or adolescent in my care · Male · 2022-07-07
Timeline
-
2021-01-14
Dose 1 — Pfizer-BioNTech
-
2021-02-05
Dose 2 — Pfizer-BioNTech
-
2021-12-14
Dose 3 — Moderna
-
2021-12-15
Registered in v-safe
-
2021-12-16
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-17
- 2021-12-18
-
2021-12-19
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-12-20
- 2021-12-21
-
2021-12-28
Survey response — day 14, dose 3MedDRA: Fatigue, Lymphadenopathy — Feeling: FairFree text: Left axillary lymphadenopathy, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-01-04
- 2022-01-11
- 2022-01-20
- 2022-01-25
- 2022-03-15
-
2022-06-14
Survey response — 6 months, dose 3MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Cold symptoms, runny nose, congestion, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-09-15
Dose 4 — Moderna
- 2022-09-16
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-29
-
2022-10-08
Survey response — day 21, dose 4MedDRA: Oropharyngeal pain, Upper-airway cough syndrome — Feeling: FairFree text: Mild post nasal drip and sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-10-13
- 2022-10-20
- 2022-10-27
-
2022-12-15
Survey response — 3 months, dose 4MedDRA: Respiratory symptom — Feeling: GoodFree text: URI symptomsMedDRA releases: 2024-11 · check-in free text available
-
2023-03-16
Survey response — 6 months, dose 4MedDRA: COVID-19, Nasopharyngitis — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | No |
| 2 | 2021-02-05 | Pfizer-BioNTech | No |
| 3 | 2021-12-14 | Moderna | No |
| 4 | 2022-09-15 | Moderna | No |
Free text
Release 10 — day 14, dose 3
Symptoms: Left axillary lymphadenopathy, fatigue
Release 12 — 6 months, dose 3
Symptoms: Cold symptoms, runny nose, congestion, cough
Release 12 — day 21, dose 4
Symptoms: Mild post nasal drip and sore throat
Release 12 — 3 months, dose 4
Symptoms: URI symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release